Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Colorectal Neoplasms, Metastases, Neoplasm

Thank you

Trial Information


Inclusion Criteria:



- Metastatic colorectal carcinoma

- Suitable for first-line treatment of metastatic disease

Exclusion Criteria:

- Peripheral neuropathy greater than Grade 1

- Adjuvant therapy within 6 months prior to study treatment

- Prior oxaliplatin

- Prior pelvic or whole abdomen radiation

- Any history of coronary angioplasty or history of myocardial infarction

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

D2820C00007

NCT ID:

NCT00065117

Start Date:

September 2003

Completion Date:

February 2004

Related Keywords:

  • Colorectal Neoplasms
  • Metastases, Neoplasm
  • metastatic
  • colorectal
  • first-line
  • adjuvant
  • cancer
  • Colorectal Cancer
  • Colorectal Carcinoma
  • Colorectal Tumors
  • Neoplasms, Colorectal
  • Neoplasms
  • Colorectal Neoplasms
  • Neoplasm Metastasis

Name

Location

Research SiteAnaheim, California  
Research SiteArlington Heights, Illinois  
Research SiteBaton Rouge, Louisiana  
Research SiteBaltimore, Maryland  
Research SiteBranson, Missouri  
Research SiteAlbany, New York  
Research SiteAsheville, North Carolina  
Research SiteAllentown, Pennsylvania